Relationship between urinary albumin and serum soluble fms-like tyrosine kinase 1 (sFlt-1) in normal pregnancy

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 128, Issue 1-2, 2006, Pages 204-208

  Yoshimatsu, Jun ^a   Matsumoto, Harunobu ^a   Goto, Kiyomi ^a   Shimano, Masako ^a   Narahara, Hisashi ^a   Miyakawa, Isao ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Albuminuria; Preeclampsia; sFlt 1; VEGF

Indexed keywords

ALBUMIN; CREATININE; PROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; STATISTICAL SIGNIFICANCE;

EID: 33748158307     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2005.11.017     Document Type: Article

References (25)

1. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 237 (1999) 1-30
2. Masuda Y., Shimizu A., Mori T., et al. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 159 (2001) 599-608
3. Eremina V., and Quaggin S.E. The role of VEGF-A in glomerular development and function. Curr Opin Nephrol Hypertens 13 (2004) 9-15
4. Shimizu A., Masuda Y., Mori T., et al. Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis. J Am Soc Nephrol 15 (2004) 2655-2665
5. Chung J.Y., Song Y., Wang Y., Magness R.R., and Zheng J. Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies. J Clin Endocrinol Metab 89 (2004) 2484-2490
6. Sgambati E., Marini M., Zappoli Thyrion G.D., et al. VEGF expression in the placenta from pregnancies complicated by hypertensive disorders. BJOG 111 (2004) 564-570
7. Chaiworapongsa T., Romero R., Espinoza J., et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol 190 (2004) 1541-1547
8. Maynard S.E., Min J.Y., Merchan J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
9. Koga K., Osuga Y., Yoshino O., et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 88 (2003) 2348-2351
10. Tsatsaris V., Goffin F., Munaut C., et al. Overexpression of the soluble vascular endothelial growth factor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 88 (2003) 5555-5563
11. Vuorela P., Helske S., Hornig C., Alitalo K., Weich H., and Halmesmaki E. Amniotic fluid-soluble vascular endothelial growth factor receptor-1 in preeclampsia. Obstet Gynecol 95 (2000) 353-357
12. George L.B. Protecting renal function in the hypertensive patient: clinical guidelines. Am J Hypertens 18 (2005) 112-119
13. Bar J., Hod M., and Erman A. Microalbuminuria as an early predictor of hypertensive complications in pregnant women at high risk. Am J Kidney Dis 28 (1996) 220-225
14. Paternoster D.M., Stella A., Mussap M., Plebani M., Gambaro G., and Grella P.V. Predictive markers of pre-eclampsia in hypertensive disorders of pregnancy. Int J Gynaecol Obstet 66 (1999) 237-243
15. Shaarawy M., and Salem M.E. The clinical value of microtransferrinuria and microalbuminuria in the prediction of pre-eclampsia. Clin Chem Lab Med 39 (2001) 29-34
16. Risberg A., Larsson A., Olsson K., Lyrenas S., and Sjoquist M. Relationship between urinary albumin and albumin/creatinine ratio during normal pregnancy and pre-eclampsia. Scand J Clin Lab Invest 64 (2004) 17-23
17. Strevens H., Wide-Swensson D., Hansen A., et al. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG 110 (2003) 831-836
18. Ballermann B.J. Glomerular endothelial cell differentiation. Kidney Int 67 (2005) 1668-1671
19. Hayman R., Brockelsby J., Kenny L., and Baker P. Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor. J Soc Gynecol Invest 6 (1999) 3-10
20. Eremina V., Sood M., Haigh J., et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111 (2003) 707-716
21. Salako B.L., Olayemi O., Odukogbe A.T., et al. Microalbuminuria in pregnancy as a predictor of preeclampsia and eclampsia. West Afr J Med 22 (2003) 295-300
22. Paternoster D.M., Stella A., Mussap M., Plebani M., Gambaro G., and Grella P.V. P redictive markers of pre-eclampsia in hypertensive disorders of pregnancy. Int J Gynaecol Obstet 66 (1999) 237-243
23. Barden A., Singh R., Walters B.N., Ritchie J., Roberman B., and Beilin L.J. Factors predisposing to pre-eclampsia in women with gestational diabetes. J Hypertens 22 (2004) 2371-2378
24. Mogensen C.E. Diabetic renal disease in patients with type 2 diabetes mellitus: new strategies for prevention and treatment. Treat Endocrinol 1 (2002) 3-11
25. Yuyun M.F., Adler A.I., and Wareham N.J. What is the evidence that microalbuminuria is a predictor of cardiovascular disease events?. Curr Opin Nephrol Hypertens 14 (2005) 271-276